SOCS3 is reported to be a modulator of macrophage, which could drive macrophage inflammatory responses and modulate the efficiency of phagocytic processes [75], indicating that SOCS3 might affect tumor progression and drug sensitivity through mediate the macrophages and monocytes in GBM. Here, SOCS3 is linked to glioblastoma.